12-O-tetradecanoylphorbol-1,3-acetate-induced degradation of protein kinase B via ubiquitin-proteasomal pathway depends on its Ser473 phosphorylation in gastric cancer cells

Folia Histochem Cytobiol. 2013;51(1):11-7. doi: 10.5603/FHC.2013.002.

Abstract

TPA (12-O-tetradecanoylphorbol-1, 3-acetate) can induce cell apoptosis and cause PKB (protein kinase B) degradation correlated with its phosphorylation in gastric cancer cells. We investigated whether the ubiquitin-proteasomal pathway is involved in TPA-induced PKB degradation. The results showed that TPA could induce PKB ubiquitination by inhibiting its phosphorylation at the serine 473 site. Moreover, MG132 (26S proteasome inhibitor) partially inhibited TPA-induced degradation of PKB. Taken together, TPA could degrade PKB via the ubiquitin-proteasomal pathway, and the suppression of PKB phosphorylation at the serine 473 site might be a prerequisite for the TPA-induced ubiquitination in gastric cancer cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • HEK293 Cells
  • Humans
  • Phosphorylation / drug effects
  • Phosphoserine / metabolism*
  • Proteasome Endopeptidase Complex / metabolism*
  • Proteolysis / drug effects*
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Signal Transduction / drug effects
  • Stomach Neoplasms / enzymology*
  • Stomach Neoplasms / pathology
  • Tetradecanoylphorbol Acetate / analogs & derivatives*
  • Tetradecanoylphorbol Acetate / pharmacology
  • Ubiquitin / metabolism*

Substances

  • 12-O-tetradecanoylphorbol-1,3-acetate
  • Ubiquitin
  • Phosphoserine
  • Proto-Oncogene Proteins c-akt
  • Proteasome Endopeptidase Complex
  • Tetradecanoylphorbol Acetate